# Markel Group Inc.: overview

MKL · NYSE · CIK 1096343 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/mkl.md) · [Financials](/companies/mkl/financials.md) · [Filings](/companies/mkl/filings.md) · [Insiders](/companies/mkl/insiders.md)

Latest reported revenue: [$4.16bn](/filings/0001096343-26-000080.md) for Q3 FY2026, three months to 2026-09-30, from the 10-Q filed Oct 28, 2026 (XBRL us-gaap:Revenues, accession 0001096343-26-000080).

## Last eight quarters

| Line item | Unit | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [3,724 d](/filings/0001096343-26-000020.md) | [3,548](/filings/0001096343-26-000041.md) | [4,023](/filings/0001096343-26-000064.md) | [3,935](/filings/0001096343-26-000080.md) | [4,008 d](/filings/0001096343-26-000020.md) | [3,551](/filings/0001096343-26-000041.md) | [4,018](/filings/0001096343-26-000064.md) | [4,158](/filings/0001096343-26-000080.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | [16.0% d](/filings/0001096343-26-000020.md) | [8.0%](/filings/0001096343-26-000041.md) | [27.5%](/filings/0001096343-26-000064.md) | [25.7%](/filings/0001096343-26-000080.md) | [19.8% d](/filings/0001096343-26-000020.md) | [(7.7%)](/filings/0001096343-26-000041.md) | [38.8%](/filings/0001096343-26-000064.md) | [9.2%](/filings/0001096343-26-000080.md) |
| Net margin | % | [14.7% d](/filings/0001096343-26-000020.md) | [3.4%](/filings/0001096343-26-000041.md) | [16.3%](/filings/0001096343-26-000064.md) | [19.1%](/filings/0001096343-26-000080.md) | [14.4% d](/filings/0001096343-26-000020.md) | [(6.0%)](/filings/0001096343-26-000041.md) | [29.1%](/filings/0001096343-26-000064.md) | [6.2%](/filings/0001096343-26-000080.md) |
| Diluted EPS | $ per share | not reported | [12.08](/filings/0001096343-26-000041.md) | [49.67](/filings/0001096343-26-000064.md) | [59.25](/filings/0001096343-26-000080.md) | not reported | [(18.90)](/filings/0001096343-26-000041.md) | [92.76](/filings/0001096343-26-000064.md) | [18.15](/filings/0001096343-26-000080.md) |
| Free cash flow | $m | [420 d](/filings/0001096343-26-000020.md) | [335](/filings/0001096343-26-000041.md) | [454 d](/filings/0001096343-26-000064.md) | [1,166 d](/filings/0001096343-26-000080.md) | [599 d](/filings/0001096343-26-000020.md) | [(31.4)](/filings/0001096343-26-000041.md) | [385 d](/filings/0001096343-26-000064.md) | [849 d](/filings/0001096343-26-000080.md) |

- Revenue. XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 12-month figure less the 9-month figure; 6-month figure less the 3-month figure; 9-month figure less the 6-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $bn | [4.0](/filings/0001096343-23-000033.md) | [5.2](/filings/0001096343-23-000033.md) | [14.3](/filings/0001096343-26-000020.md) | [14.8](/filings/0001096343-26-000020.md) | [15.5](/filings/0001096343-26-000020.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | [81.1%](/filings/0001096343-24-000025.md) | [(1.8%)](/filings/0001096343-25-000027.md) | [20.5%](/filings/0001096343-26-000020.md) | [25.1%](/filings/0001096343-26-000020.md) | [20.6%](/filings/0001096343-26-000020.md) |
| Net margin | % | [60.6%](/filings/0001096343-24-000025.md) | [(4.1%)](/filings/0001096343-25-000027.md) | [14.0%](/filings/0001096343-26-000020.md) | [18.5%](/filings/0001096343-26-000020.md) | [13.6%](/filings/0001096343-26-000020.md) |
| Diluted EPS | $ per share | [176.38](/filings/0001096343-24-000025.md) | [(23.72)](/filings/0001096343-25-000027.md) | [146.98](/filings/0001096343-26-000020.md) | [199.32](/filings/0001096343-26-000020.md) | [169.22](/filings/0001096343-26-000020.md) |
| Free cash flow | $bn | [2.1](/filings/0001096343-24-000025.md) | [2.5](/filings/0001096343-25-000027.md) | [2.5](/filings/0001096343-26-000020.md) | [2.3](/filings/0001096343-26-000020.md) | [2.6](/filings/0001096343-26-000020.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax; Revenue: us-gaap:Revenues.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax; Revenue: us-gaap:Revenues.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax; Revenue: us-gaap:Revenues.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax; Revenue: us-gaap:Revenues.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/mkl/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $1.36bn | 697,836 |  | Reduced −12,770 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $1.07bn | 545,650 |  | Added +1,143 |
| [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $1.02bn | 521,976 |  | Reduced −2,225 |
| [Davis Selected Advisers](/funds/1036325.md) | 2026-06-30 | $794.4m | 406,759 |  | Added +23,326 |
| [MORGAN STANLEY](/funds/895421.md) | 2026-06-30 | $684.8m | 350,660 |  | Reduced −6,427 |
| [Select Equity Group, L.P.](/funds/1592643.md) | 2026-06-30 | $647.8m | 331,679 |  | Reduced −45,964 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $609.7m | 312,169 |  | Added +5,179 |
| [PRINCIPAL FINANCIAL GROUP INC](/funds/1126328.md) | 2026-06-30 | $601.2m | 307,791 |  | Reduced −94,085 |
| [Boston Partners](/funds/1386060.md) | 2026-06-30 | $600.5m | 307,500 |  | Added +56,528 |
| [VAN LANSCHOT KEMPEN INVESTMENT MANAGEMENT N.V.](/funds/1367401.md) | 2026-06-30 | $450.4m | 230,637 |  | Added +4,489 |

## Recent filings

[All 1,710 filings](/companies/mkl/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-28 | 17:19 ET | [8-K](/filings/0001096343-26-000082.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001096343-26-000082 |
| 2026-10-28 | 16:36 ET | [10-Q](/filings/0001096343-26-000080.md) | Quarterly report, period 2026-09-30 | 0001096343-26-000080 |
| 2026-09-14 | 16:12 ET | [SCHEDULE 13D/A](/filings/0000905148-26-004169.md) | Ownership report, active investor, amended | 0000905148-26-004169 |
| 2026-09-08 | 08:30 ET | [8-K](/filings/0001096343-26-000074.md) | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001096343-26-000074 |
| 2026-07-29 | 16:31 ET | [10-Q](/filings/0001096343-26-000064.md) | Quarterly report, period 2026-06-30 | 0001096343-26-000064 |
| 2026-05-22 | 16:31 ET | [8-K](/filings/0001096343-26-000050.md) | 9.01 Financial statements and exhibits | 0001096343-26-000050 |
| 2026-05-20 | 14:00 ET | [8-K](/filings/0001096343-26-000046.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001096343-26-000046 |
| 2026-04-28 | 16:31 ET | [10-Q](/filings/0001096343-26-000041.md) | Quarterly report, period 2026-03-31 | 0001096343-26-000041 |
| 2026-04-15 | 18:55 ET | [SCHEDULE 13D/A](/filings/0000905148-26-001695.md) | Ownership report, active investor, amended | 0000905148-26-001695 |
| 2026-04-02 | 08:03 ET | [DEF 14A](/filings/0001096343-26-000033.md) | Proxy statement, period 2026-04-02 | 0001096343-26-000033 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001096343-26-000020.md), filed Feb 26, 2026.

## Forecast league

Q3 FY2026, the quarter ended 2026-09-30, has been scored from the reported figures. [See the target](/leagues/2026q3/targets/5a9dfd11-3a92-4418-95c1-600155f0855d)

## About the filer

- CIK: 1096343
- Tickers: MKL
- Exchange: NYSE
- SIC code: 6331 Fire, Marine & Casualty Insurance
- State of incorporation: VA
- Filer category: Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 30, 2026, 16:44 ET. No prices; not investment advice.